These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1657503)

  • 1. Stanozolol stimulates remodelling of trabecular bone and net formation of bone at the endocortical surface.
    Benéton MN; Yates AJ; Rogers S; McCloskey EV; Kanis JA
    Clin Sci (Lond); 1991 Oct; 81(4):543-9. PubMed ID: 1657503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.
    Chesnut CH; Ivey JL; Gruber HE; Matthews M; Nelp WB; Sisom K; Baylink DJ
    Metabolism; 1983 Jun; 32(6):571-80. PubMed ID: 6341772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the anabolic steroid stanozolol on cells derived from human bone.
    Vaishnav R; Beresford JN; Gallagher JA; Russell RG
    Clin Sci (Lond); 1988 May; 74(5):455-60. PubMed ID: 3259487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone histomorphometric evaluation of pamidronate treatment in clinically manifest osteoporosis.
    Bravenboer N; Papapoulos SE; Holzmann P; Hamdy NA; Netelenbos JC; Lips P
    Osteoporos Int; 1999; 9(6):489-93. PubMed ID: 10624455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stanozolol Decreases Bone Turnover Markers, Increases Mineralization, and Alters Femoral Geometry in Male Rats.
    Nebot E; Aparicio VA; Camiletti-Moirón D; Martinez R; Erben RG; Kapravelou G; Sánchez-González C; De Teresa C; Porres JM; López-Jurado M; Aranda P; Pietschmann P
    Calcif Tissue Int; 2016 Jun; 98(6):609-18. PubMed ID: 26801156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ; Caulin F
    Bone; 1986; 7(1):17-22. PubMed ID: 3964494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis.
    Dalle Carbonare L; Arlot ME; Chavassieux PM; Roux JP; Portero NR; Meunier PJ
    J Bone Miner Res; 2001 Jan; 16(1):97-103. PubMed ID: 11149495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry.
    Glendenning P; Kent GN; Adler BD; Matz L; Watson I; O'Driscoll GJ; Hurley DM
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):347-55. PubMed ID: 10435061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
    Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phosphorus supplementation on serum parathyroid hormone and bone morphology in osteoporosis.
    Goldsmith RS; Jowsey J; Dubé WJ; Riggs BL; Arnaud CD; Kelly PJ
    J Clin Endocrinol Metab; 1976 Sep; 43(3):523-32. PubMed ID: 956340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcium and stanozolol on calcitonin secretion in patients with femoral neck fracture.
    Beringer TR; Ardill J; Taggart HM
    Bone Miner; 1986 Sep; 1(4):289-95. PubMed ID: 3333017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and cellular changes during bone growth in healthy children.
    Parfitt AM; Travers R; Rauch F; Glorieux FH
    Bone; 2000 Oct; 27(4):487-94. PubMed ID: 11033443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
    Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
    Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone remodeling and calcium metabolism: a correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's Disease.
    Lauffenburger T; Olah AJ; Dambacher MA; Guncaga J; Lentner C; Haas HG
    Metabolism; 1977 Jun; 26(6):589-606. PubMed ID: 404501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
    Recker RR; Marin F; Ish-Shalom S; Möricke R; Hawkins F; Kapetanos G; de la Peña MP; Kekow J; Farrerons J; Sanz B; Oertel H; Stepan J
    J Bone Miner Res; 2009 Aug; 24(8):1358-68. PubMed ID: 19338452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone.
    Boyce RW; Paddock CL; Franks AF; Jankowsky ML; Eriksen EF
    J Bone Miner Res; 1996 May; 11(5):600-13. PubMed ID: 9157775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary osteoporosis and the microanatomy of trabecular bone.
    Aaron JE; Johnson DR; Paxton S; Kanis JA
    Clin Rheumatol; 1989 Jun; 8 Suppl 2():84-8. PubMed ID: 2667873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.